Yui Hatanaka

<i><scp>ALK</scp></i>,<i><scp>ROS</scp>1</i> and <i><scp>NTRK</scp>3</i> gene rearrangements in inflammatory myofibroblastic tumours

Hidetaka Yamamoto, Akihiko Yoshida, Kenichi Taguchi et al. · Histopathology · 2015 · 205 citations

Screening for long noncoding RNAs associated with oral squamous cell carcinoma reveals the potentially oncogenic actions of DLEU1

Koyo Nishiyama, Reo Maruyama, Takeshi Niinuma et al. · Cell Death and Disease · 2018 · 55 citations · Full text

Oncology, Oncogenic Agent, Medicine +15

Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland

Masanobu Sato, Hidetaka Yamamoto, Yui Hatanaka et al. · Pathology - Research and Practice · 2018 · 50 citations · Full text

Tumor Biology, Tumoral Pathology, Basal Cell Adenoma +6

Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma

Takafumi Nakano, Hidetaka Yamamoto, Torahiko Nakashima et al. · Human Pathology · 2015 · 29 citations

Molecular Subclassification, Medicine, Cancer Growth +8

DLEU1 promotes oral squamous cell carcinoma progression by activating interferon-stimulated genes

Yui Hatanaka, Takeshi Niinuma, Hiroshi Kitajima et al. · Scientific Reports · 2021 · 19 citations · Full text